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Dendritic cells (DCs) are thought to play a crucial role in the pathogenesis of HIV-1 infection. DCs are believed to transport
virus particles to lymph nodes before transfer to CD41 lymphocytes. We have investigated the role of Nef in these processes.
HIV-1 replication was examined in human immature DC-lymphocyte cocultures and in DCs or lymphocytes separately. Using
various R5-tropic and X4-tropic HIV-1 strains and their nef-deleted (Dnef) counterparts, we show that Nef is required for
optimal viral replication in immature DC-T cells clusters and in T lymphocytes. Nef exerts only a marginal role on viral
replication in immature DCs alone as well as on virion capture by DCs, long-term intracellular accumulation and transmission
of X4 strains to lymphocytes. We also show that wild-type and Dnef virions are similarly processed for MHC-I restricted
exogenous presentation by DCs. Taken together, these results help explain how HIV-1 Nef may affect viral spread and
immune responses in the infected host. © 2001 Academic Press
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The nef gene is required for efficient in vivo replication
nd pathogenicity of human and simian immunodefi-
iency viruses (Cullen, 1998; Harris, 1996). Experimental
nfection of macaques with SIVmacDnef is characterized
y a low level of viral replication (Chakrabarti et al., 1995;
estler et al., 1991). In humans, several long-term non-
rogressors have been identified, in which only nef-
eleted proviruses were detected (Deacon et al., 1995;
Kirchoff et al., 1995). These individuals display low viral
loads and remained healthy for more than a decade,
although some HIVDnef-infected patients show signs of
immune defects (Greenough et al., 1999). The cellular
and virological mechanisms responsible for this role in
vivo remain unclear. Multiple activities of Nef have been
described in vitro: Nef interferes with cellular signal
transduction pathways and interacts with a number of
kinases (Saksela, 1997). Nef down-regulates the cell
surface expression of CD4, the primary receptor for HIV
and SIV (Guy et al., 1987; Piguet et al., 1999). Reduced
CD4 surface levels could prevent superinfections, in-
crease the life span of viral envelope-expressing cells,
enhance envelope incorporation into virions, and alter
activity of CD41 T cells (Benson et al., 1993; Lama et al.,
999; Ross et al., 1999; Schwartz et al., 1993; Skowronski
1 To whom correspondence and reprint requests should be ad-
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225t al., 1993). Nef also down-regulates the surface expres-
ion of major histocompatibility complex class I mole-
ules (MHC-I) (Le Gall et al., 1998; Schwartz et al., 1996),
reventing the recognition and lysis of infected cells by
oth CD81 cytotoxic T lymphocytes (CTLs) and NK cells
(Cohen et al., 1999; Collins et al., 1998). In addition, Nef
exerts direct positive effects on the virus life cycle in
primary human lymphocytes and in macrophages (Aiken
and Trono, 1995; de Ronde et al., 1992; Glushakova et al.,
1999; Miller et al., 1994; Spina et al., 1994), probably by
facilitating early (entry or postentry) steps of the replica-
tive cycle (Aiken and Trono, 1995; Miller et al., 1994;
Schwartz et al., 1995). Finally, Nef mediates lymphocyte
chemotaxis and activation when expressed in macro-
phages, indicating that the viral protein may also play a
role in lymphocyte recruitment (Swingler et al., 1999).
Dendritic cells (DCs) are also natural targets of HIV-1
replication. However, the importance of Nef for viral rep-
lication in these cells remains poorly documented.
DCs are the most potent antigen presenting cells that
can stimulate resting naive T lymphocytes and initiate
CTL responses (Banchereau and Steinman, 1998). Imma-
ture DCs residing in peripheral tissues, including the
skin and several mucosal surfaces, are specialized in
capturing and processing antigens. Immature DCs do
not express high levels of surface molecules required for
potent T-cell stimulation. After antigen capture, DCs ma-
ture and travel toward secondary lymphoid organs, pro-
cessing antigens for presentation and acquiring the ca-
0042-6822/01 $35.00
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226 PETIT ET AL.pacity to attract and activate resting CD81 CTLs during
that journey. DCs are believed to play a crucial role in the
pathogenesis of HIV-1 infection (Banchereau and Stein-
man, 1998; Blauvelt, 1997; Knight and Patterson, 1997;
Rowland-Jones, 1999). Immature DCs in mucosal tissues
may represent the initial targets for HIV during primary
infection, and these cells are suspected to be responsi-
ble for the transport of virus to lymph nodes and transfer
to CD41 lymphocytes (Banchereau and Steinman, 1998;
Blauvelt, 1997; Knight and Patterson, 1997; Rowland-
Jones, 1999).
DCs express low levels of the HIV receptors CD4 and
CCR5 (Ayehunie et al., 1997; Granelli-Piperno et al., 1996;
Klagge and Schneider-Schaulies, 1999; O’Doherty et al.,
1993; Rubbert et al., 1998). DCs are considered either
egative or weakly positive for CXCR4 expression, de-
ending on the study (Ayehunie et al., 1997; Granelli-
iperno et al., 1996; Klagge and Schneider-Schaulies,
999; Rubbert et al., 1998). These contradictory results
ay be due to different maturation states of DCs, which
egulate chemokine receptor surface expression (Lin et
l., 1998). HIV-1 replicates rather inefficiently in DCs.
5-tropic, but not X4-tropic, HIV-1 strains induce chemo-
axis and replicate in immature DCs (Granelli-Piperno et
l., 1998; Lin et al., 2000). However, both R5- and X4-
ropic HIV-1 readily bind and enter DCs (Ayehunie et al.,
997; Granelli-Piperno et al., 1999, 1996; Klagge and
Schneider-Schaulies, 1999). HIV-1 transmission from
DCs to T cells involves a DC-specific receptor, DC-SIGN,
which binds viral envelope glycoproteins and retains the
attached virus in an infectious state (Geijtenbeek et al.,
2000). Interestingly, DC-T cell clusters are the sites of
extremely efficient HIV-1 (Cameron et al., 1992; Granelli-
iperno et al., 1998, 1999; Pope et al., 1994) and SIV
Ignatius et al., 1998; Messmer et al., 2000; Pope et al.,
1997) replication in culture, and evidence exists for an
active HIV-1 replication within DC-T clusters in lymphoid
tissues (Frankel et al., 1996).
The observation that Nef affects viral loads as soon as
the early stages of infection in humans and monkeys
(Chakrabarti et al., 1995; Deacon et al., 1995; Kestler et
al., 1991; Kirchoff et al., 1995) suggests that this factor
may play an important role in the interactions between
HIV-1, DCs, and T cells. Recently, Messmer et al. reported
that SIVmac239Dnef displayed decreased replicative ca-
pacity in cocultures of simian immature DCs and T cells
(Messmer et al., 2000). However, because immature DCs
are not susceptible to SIVmac239 replication, whether
SIV Nef is required for viral replication in DCs or for viral
transmission from DCs to T cells could not be deter-
mined in this study (Messmer et al., 2000). We have
investigated here the role of Nef on HIV-1 replication in
human immature DCs-T cell cocultures and in separate
cultures of DCs or lymphocytes. Using various R5 and X4
HIV-1 strains and their nef-deleted counterparts, we re-
port that in mixtures of immature DCs and T cells, thelevel of replication of Dnef was significantly lower than
that of the wild-type. Altogether, our results indicate that
Nef is required for optimal viral replication in immature
DC-T cell clusters and in T lymphocytes, but exerts only
a marginal role in immature DCs. We also show that
wild-type and Dnef virions are similarly captured and
processed for MHC-I restricted exogenous presentation
by DCs.
RESULTS
Role of Nef on HIV-1 replication in immature DC-T
cell cultures
To investigate the role of Nef on HIV-1 replication in
primary immature DC-T cell cultures, we compared the
kinetics of viral growth of WT and Dnef isogenic viruses.
Immature DCs have been reported to express CD4 and
CCR5, albeit at lower levels than on T cells (Ayehunie et
al., 1997; Granelli-Piperno et al., 1996; O’Doherty et al.,
1993). Flow cytometry analysis indicated that monocyte-
derived immature DCs used in this study expressed CD4,
low levels of CCR5, and virtually no CXCR4 at the cell
surface (Fig. 1A). Since HIV replication in DCs depends
on the tropism of the virus (Granelli-Piperno et al., 1998),
we analyzed the replication of two R5 isolates, NLAD8
and YU-2, and one X4 isolate, NL43. Immature DCs were
exposed to low virus doses (7 ng of p24 per 2 3 105 cells)
in an overnight incubation; cells were then washed to
remove extracellular virus and mixed with autologous T
lymphoblasts that had been activated 3 days before
coculture. Viral replication was assessed by measuring
p24 production in cell supernatants. All three WT viruses
replicated in these mixed cultures (Fig. 1B). With NLAD8
and YU-2, the levels of p24 production reached 100–200
ng/ml at days 8–12 postinfection (pi). They were lower
with NL43 (peak at 20 ng/ml), suggesting that R5 strains
replicate more efficiently than X4 strains in DC-T cell
cultures. Interestingly, Dnef replication was significantly
impaired when compared to WT viruses (Fig. 1B). More-
over, the defect of Dnef viruses varied with the viral
strain. NLAD8Dnef replication was moderately affected,
with about a threefold reduction in p24 production when
compared to WT virus (Fig. 1B). With YU-2 and NL43
isolates, Dnef replication was more dramatically im-
paired, reaching only 5–10 ng p24/ml at day 12 pi. This
corresponded to about a 10-fold reduction in p24 pro-
duction when compared with WT viruses. Therefore, HIV
replication is significantly affected in primary DC-T cell
cultures in the absence of Nef. The replicative defect of
Dnef viruses is observed with both R5 and X4 strains and
is thus independent of viral tropism. Of note, a similar
defect of Dnef viruses was observed when cells were
infected with a 10-fold higher viral inoculum (not shown)
or when immature DCs were mixed with heterologous
activated T cells (not shown).
One attractive feature of the DC-T coculture model is
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FIG. 1. Surface expression of HIV receptors in immature DCs and rep
evels of HIV receptors CD4, CXCR4, and CCR5 in immature DCs. Cell
Abs and revealed with a phycoerythrin-labeled secondary antibody. C
sotypic mAb. (B) Replication of isogenic WT and Dnef isogenic HIV-1 in
viruses (7 ng of p24). After overnight incubation, cells were washed to re
had been activated 3 days before (top) or with 8 3 105 autologous n
roduction in the culture supernatants over a 12-day period. Days pi:of T cells. We therefore examined the effects of Nef
deletion on viral replication in cocultures of DCs andautologous nonactivated PBLs. All three WT viruses rep-
n of HIV-1 WT and Dnef in immature DCs-T cell cocultures. (A) Surface
stained with Leu3A (anti-CD4), 12G5 (anti-CXCR4), or 2D7 (anti-CCR5)
ere analyzed by flow cytometry. CTRL, cells stained with an irrelevant
re DCs-T cell cocultures. DCs (2 3 105) were exposed to the indicated
unbound viruses and mixed with 8 3 105 autologous lymphoblasts that
ated lymphocytes. Viral replication was assessed by measuring p24
stinfection. Data are representative of three experiments.licatio
s were
ells w
immatulicated in these mixed cultures (Fig. 1B). Levels of p24
production were much lower than when PBMCs were
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228 PETIT ET AL.activated before coculture. With NLAD8 and YU-2, p24
production reached 10 ng/ml at days 12–14 pi and was
even lower with NL43 (peak below 5 ng/ml). Of note,
none of the three viral strains replicated in nonactivated
PBMCs alone (not shown), confirming that viral replica-
tion in this experimental system requires the presence of
DCs. As for DC-activated T-cell cocultures, Dnef replica-
tion was significantly impaired when compared to WT
viruses, and the Dnef defect varied with the viral strain
(Fig. 1B). When compared to WT, NLAD8Dnef replication
was moderately affected, with about a twofold reduction
in p24 production virus. With YU-2 and NL43 isolates,
Dnef defect was more marked (Fig. 1B). Altogether, these
experiments indicate that Nef is required for efficient
HIV-1 replication in DC-T cell cultures irrespective of the
activation state of T lymphocytes.
Influence of Nef on HIV-1 replication in immature DCs
We then characterized the replicative defect of Dnef
viruses in immature DC-T cell cocultures. More precisely,
we examined the role of Nef on viral replication in im-
mature DCs and in T cells separately, and on viral trans-
mission from immature DCs to T lymphocytes. To study
the role of Nef on HIV-1 replication in immature DCs, we
compared the viral growth of WT and Dnef isogenic
NLAD8, YU-2, or NL43 strains. We used two viral inputs
(7 and 50 ng of p24 per 2 3 105 target cells, respectively),
since the effect of Nef may be more pronounced at low
viral doses (Miller et al., 1994; Spina et al., 1994). What-
ver the viral input, both NLAD8 and YU-2 strains repli-
ated in immature DCs, whereas NL43 was unable to
row in these cells (Fig. 2A). This confirmed the finding
hat immature DCs selectively replicate R5-tropic HIV-1
Granelli-Piperno et al., 1998). At the lower viral input,
hich was the same as that used in immature DCs-T cell
ocultures, replication of WT NLAD8 or YU-2 reached
–3 ng p24/ml at day 12 pi (Fig. 2). Therefore, as previ-
usly reported (Cameron et al., 1992; Frank et al., 1999;
ranelli-Piperno et al., 1998; Pope et al., 1995), viral
eplication is much less efficient in immature DCs than in
Cs-T cell cocultures (compare p24 levels in Figs. 2A
nd 1B). At the higher viral input, virus production
eached 30 and 80 ng of p24 for NLAD8 and YU-2,
espectively (Fig. 2A).
Interestingly, the replication of Dnef viruses was not, or
nly slightly, affected in DCs. NLAD8 WT and Dnef
yielded similar p24 production levels at high viral input.
Even at the lower viral input, replication of NLAD8Dnef
was not significantly affected (Fig. 2A). Similarly, only a
slight difference (less than twofold) was observed be-
tween YU-2 WT and Dnef viruses (Fig. 2A). Altogether,
these results indicate that R5 HIV-1 strains are able to
replicate in immature DCs, albeit with a low efficiency.
Moreover, Nef is only marginally necessary for HIV-1
replication in immature DCs.
o
iRole of Nef on HIV-1 replication in primary
lymphocytes
Since HIV-1 replication in immature DCs is not signifi-
cantly affected by the absence of Nef, we next studied the
growth of WT and Dnef isogenic NLAD8, YU-2, or NL43
strains in primary lymphocytes. The importance of Nef on
HIV replication in PBMCs has been demonstrated (Aiken
and Trono, 1995; de Ronde et al., 1992; Glushakova et al.,
1999; Miller et al., 1994; Spina et al., 1994). In some studies,
it has been reported that HIVDnef replicated poorly only in
D41 cells stimulated after infection, when virus inoculum
was low (Miller et al., 1994; Spina et al., 1994). In others, the
eplicative defect was also manifest in fully activated PB-
Cs and was independent of the multiplicity of infection
Aiken and Trono, 1995; de Ronde et al., 1992). In the
mmature DC-T cell cultures in which HIVDnef replication
as impaired (Fig. 1), we used lymphocytes which had
een activated before incubation with virus-exposed DCs.
e therefore used the same protocol and analyzed viral
eplication in PBLs that had been activated with PHA 3 days
efore infection. As for immature DCs, we used two viral
nputs (7 and 50 ng of p24 per 8 3 105 target cells, respec-
tively). Wild-type NLAD8, YU-2, and NL43 induced p24 pro-
duction in supernatants of infected cells (Fig. 2B), confirm-
ing that R5 and X4 strains replicate in PBLs. Both strains
efficiently replicate and reached equivalent peaks of p24
production at each viral inoculum (100–150 ng p24/ml for
NLAD8, 25–50 ng p24/ml for YU-2 and NL43). In contrast,
the replicative capacity of Dnef mutants was dramatically
ffected. As in immature DC-T cell cultures, the defect of
nef viruses varied with the viral strain. NLAD8Dnef repli-
ation was only two- to threefold lower than WT virus (Fig.
B). With YU-2 and NL43 isolates, Dnef replication was
ore significantly impaired (Fig. 2B). Nef-mutated viruses
eplicated very poorly, even at the higher viral inoculum,
lateauing at only 5 ng/ml p24. Taken together, these re-
ults demonstrated a consistently positive influence of Nef
n HIV-1 replication in primary lymphocytes.
The absolute levels of viral replication, as well as the
efects of nef-deleted viruses in primary cells, may vary
ccording to donors. To obtain a better insight of the
nfluence of Nef on viral replication, results from three to
ive independent experiments are shown in Fig. 3. Dif-
erences between WT and Dnef replication levels were
xpressed as ratios of p24 concentrations at the peak of
iral production, with 100% corresponding to WT values.
alculations were performed for each viral strain and for
ach culture condition, including DCs and activated T
ells separately and DC-activated T cell cocultures. Irre-
pective of cell culture conditions, Dnef virus defect was
inimal with NLAD8 strain, whereas it was much more
ronounced with YU-2 and NL43 strains (Fig. 3). There-
ore, the replicative defect associated with the absence
f Nef is strain-dependent. Since NLAD8 and NL43 are
sogenic viruses differing only in the env gene, our result
N
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229Nef AND HIV REPLICATION IN DENDRITIC T-CELL COCULTURESindicates that the Nef defect may be modulated by Env
proteins. Data also indicates that Nef requirement for
optimal viral growth varied with cell culture conditions. In
immature DCs-T cell cocultures, Dnef replicated less
efficiently than WT (2-fold, 10-fold, and 5-fold reduction of
FIG. 2. HIV-1 WT and Dnef replication in separate cultures of immat
(8 3 105 cells, B) were exposed to either 50 ng (high inoculum panel) o
incubation, cells were washed to remove unbound virus. Viral replicat
Data are representative of three experiments.p24 peak levels for NLAD8, YU-2, and NL43, respectively).
In immature DCs alone, the effect of Nef was less obvious
(
p(Dnef p24 levels reduced to 75 and 60% of those of WT for
LAD8 and YU-2, respectively). In contrast, Nef was re-
uired for efficient virus production in lymphocytes, as p24
evels reached by Dnef viruses were 4-, 10-, and 20-fold
ower than for WT NLAD8, NL43, and YU-2, respectively
s and activated PBLs. DCs (2 3 105 cells, A) and PHA-activated PBLs
(low inoculum panel) p24 of the indicated viral strains. After overnight
assessed by measuring p24 production in the culture supernatants.ure DC
r 7 ng
ion wasFig. 3). Taken together, these experiments indicate a more
rominent role of Nef in lymphocytes than in DCs.
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230 PETIT ET AL.Role of Nef during transmission of X4-tropic HIV-1
from DC to T cells
Since Nef is required for efficient HIV-1 replication in
DCs-T cell cocultures, the transmission step between
DCs and T cells may be impaired with Dnef viruses. We
therefore developed an experimental system allowing
the study of the capacity of DCs to transmit infectious
viral particles. Since R5 strains replicate in immature
FIG. 3. Comparison of HIV-1 WT and Dnef replication in immature D
ere infected as described in Figs. 1–2 with the indicated viral strains
upernatants. WT and Dnef replication levels were compared by calc
orresponding to WT values. Data are mean 6 SD of three to five ind
mmature DCs.DCs even in the absence of T cells (see Fig. 2A), it was
important to use an X4 strain (NL43) for this analysis.
7 ng of p24) (C). A 5-day incubation period at 37°C of cell-free NL43 WT or D
y measuring p24 production in the culture supernatants over a 14-day perioWith the aim to overcome possible artifacts that could
result from the altered replication of NL43Dnef in PBLs
(see Fig. 2B), DCs were cocultivated with immortalized T
cells, in which Nef is dispensable for viral replication
(Aiken and Trono, 1995; Miller et al., 1994; Schwartz et al.,
1995; Spina et al., 1994). As we previously reported (Le
all et al., 1997; Schwartz et al., 1995), cell-free infection
f the CD41 lymphoid line MT4 with NL43 WT or Dnef
5
ated PBLs cocultures, in immature DCs, and in activated PBLs. Cells
replication was assessed by measuring p24 production in the culture
the ratio of p24 released at the peak of viral production with 100%
nt experiments. N.A., not applicable since NL43 does not replicate invirions (7 ng of p24 per 8 3 10 cells) produced equiva-
lent amounts of p24 with similar kinetics (Fig. 4C). ToFIG. 4. Viral transmission and stability of HIV-1 WT and Dnef viruses after capture by immature DCs. Immature DCs (2 3 105) were exposed to NL43
WT or Dnef (7 ng of p24). After overnight incubation, cells were washed to remove unbound virus. Cells were then mixed with 8 3 105 MT4 cells (A)
r incubated 5 days before addition of 8 3 105 MT4 cells (B). As a control, MT4 cells (8 3 105) were directly exposed to cell-free NL43 WT or DnefC-activ
. Viral
ulatingnef fully abrogates viral infectivity (D). Viral replication was assessed
d. Data are representative of two experiments.
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231Nef AND HIV REPLICATION IN DENDRITIC T-CELL COCULTURESmonitor the transmission of viral particles from DCs to
MT4 cells, DCs were pulsed overnight with NL43 WT or
Dnef virions (7 ng of p24 per 2 3 105 cells). Cells were
hen washed extensively to remove extracellular virions
nd mixed with MT4 cells. Efficient replication occurred
n recipient MT4 cells (Fig. 4A). The same kinetics were
bserved for WT and Dnef viruses (Fig. 4A), indicating
hat Nef is dispensable for transmitting viral particles
rom DCs to MT4 cells.
It has been reported recently that transmission of
IV-1 from DCs to T cells involves a specific DC receptor,
C-SIGN, which binds the viral envelope protein and
etains the captured virus in an infectious state (Geijten-
eek et al., 2000). Using THP1 monocytoid cell lines
tably expressing DC-SIGN, it was demonstrated that
his molecule is able to capture and retain HIV-1 for more
han 4 days, after which the virus can still infect permis-
ive target cells (Geijtenbeek et al., 2000). We thus ex-
mined whether immature DCs are able to capture viral
articles for long period of times and the influence of Nef
n this process. DCs were pulsed overnight with NL43
T and Dnef virions (7 ng of p24 per 2 3 105 cells). Cells
were then washed extensively and 5 days later they were
mixed with MT4 cells. Efficient viral replication occurred
only after addition of recipient MT4 cells (Fig. 4B). Again,
similar kinetics of viral production were observed for WT
and Dnef viruses (Fig. 4B). Of note, a 5-day incubation at
37°C in culture medium of cell-free NL43 WT and Dnef
abolished viral infectivity (Fig. 4D). Therefore, primary
immature DCs are able to capture and retain HIV-1 in an
infectious state for at least 5 days. NL43Dnef particles
were captured and transmitted to target cells as effi-
ciently as their WT counterparts, even after 5 days. Alto-
gether, these experiments strongly suggest that Nef
does not affect virion capture, long-term intracellular
accumulation, and transmission of X4 strains to T lym-
phocytes by DCs.
Role of Nef on MHC-I restricted presentation of HIV-1
virion antigens by DCs
A major function of DCs is to stimulate resting naive T
lymphocytes and to initiate primary CTL responses
(Banchereau and Steinman, 1998). We have recently
shown that immature DCs capture and process incoming
HIV-1 virions through the MHC-I-restricted presentation
pathway, leading to CTL activation in the absence of viral
protein neosynthesis (Buseyne et al., 2001). Presentation
of exogenous HIV-1 antigens required adequate virus-
receptor interactions and fusion of viral and cellular
membranes. We compared the ability of WT and Dnef
virions to be processed for presentation by this exoge-
nous MHC-I-restricted pathway. To this aim, immature
HLA-A21 DCs were exposed to various HIV-1 virions in
the presence of AZT, to inhibit reverse transcription and
subsequent synthesis of viral proteins. After overnight
w
cincubation, extracellular particles were washed away
and DCs were cocultivated with the HLA-A2-restricted
CD81 CTL cell line EM71-1. EM71-1 cells were derived
rom an HIV-infected patient and recognize a well-char-
cterized immunodominant epitope of the Gag p17 pro-
ein (Buseyne et al., 2001). DCs pulsed with the synthetic
ag epitope (SL9) activated EM71-1 cells specifically, as
easured by IFN-g production in an Elispot assay (Fig.
5A). This epitope is present in BRU (which is a X4-tropic
strain) and YU-2, but not in NL43 or NLAD8 isolates
(Buseyne et al., 2001). We first tested the ability of imma-
ture DCs to present the Gag epitope after exposure to
the BRU isolate. We observed that DCs pulsed with
either WT or Dnef viruses efficiently activated EM71-1
cells (Fig. 5A). Immature DCs also efficiently activated
effector cells upon exposure to the YU-2 strain (Fig. 5B).
Again, no significant difference was noted between WT
and Dnef viruses, at either high or low viral inoculum (Fig.
5B). Of note, HLA-A22 DCs exposed to various HIV
strains were not recognized by EM71-1 cells (not shown),
indicating that the exogenous presentation of HIV-1
epitopes is appropriately MHC-I restricted. Altogether,
these experiments indicate that DCs present a Gag
epitope upon exposure to incoming virions in the ab-
sence of viral protein neosynthesis. The exogenous pre-
sentation is observed with similar efficiencies with WT
and nef-deleted virions. Therefore, the presence of Nef in
virus producer cells does not significantly influence the
ability of progeny virions entering DCs to be processed
for exogenous MHC-I presentation.
DISCUSSION
We demonstrate here deficient replication of various
nef-deleted HIV strains in immature DC-T cell cocultures.
DCs are thought to play a crucial role in HIV-1 transmis-
sion and propagation. Immature DCs residing in the skin
and the mucosa might be the first cell targets of HIV-1.
They are believed to transport virus particles and trans-
mit a vigorous infection to T cells in lymph nodes (Cam-
eron et al., 1996; Knight and Patterson, 1997). Although
there is considerable evidence that DCs from blood,
skin, or lymphoid organs harboring HIV-1 can be found in
patients, the contribution of infected DCs to viral burden
is probably marginal (Cameron et al., 1996). In contrast,
HIV-1 replication is intense in conjugates of DCs and T
cells (Cameron et al., 1996) and active viral production
has been demonstrated in lymphoid tissues in DC–lym-
phocyte clusters (Frankel et al., 1996). In vivo, the Nef
gene product confers a replicative advantage as early as
the acute phase of infection (Chakrabarti et al., 1995;
Kestler et al., 1991). The main conclusion of our study is
that high levels of viral replication would occur when
DCs exposed to wild-type virus encounter CD41 T cells,hereas Dnef virus would disseminate much less effi-
iently in this environment.
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232 PETIT ET AL.In vitro, HIV-1 produced in DC–lymphocyte cocultures
probably originates from different sources. A high viral
production from DC-T cell syncytia, due to the coexpres-
sion of transcription factors, has been reported (Granelli-
Piperno et al., 1995). However, analysis of the cellular
components of virions indicated that virus produced from
immature DC-T cell cocultures primarily originates from T
cells (Frank et al., 1999). We have dissected the replica-
tive defect of Dnef HIV-1 in immature DC-T cocultures.
The replication rates of HIV-1 in immature DCs alone
were equivalent for wild-type and Dnef, whereas the
most dramatic replicative defect of Dnef HIV-1 was ob-
served in lymphocytes. Therefore, the compromised rep-
lication of Dnef in DCs-T cells mixture is most likely due
to the lymphocytic component of the coculture, rather
than to immature DCs. Although initially controversial, it
is currently believed that purified DCs do not replicate
HIV-1 with high efficiency (Cameron et al., 1996; Granelli-
Piperno et al., 1998, 1999). Accordingly, we report here
that the X4 strain NL43 does not grow in immature DCs,
whereas levels of viral production of the R5 stains YU-2
and NLAD8 were about 10–100 times lower in DCs alone
than in T cells or in DCs-T cell cocultures. Furthermore,
this low virus production was almost unchanged with
Dnef viruses. This marginal effect of Nef in immature
DCs could be due to a reduced number of replicative
cycles of HIV-1, which will be consistent with the low
levels of viral production in these cells. Alternatively,
immature DCs might be “permissive” for Dnef replication,
in a situation reminiscent of that of Vif (Madani and
Kabat, 1998; Simon et al., 1998). On the other hand, our
observation that Nef is not required for viral replication in
FIG. 5. MHC-I presentation of a Gag epitope derived from incomi
individuals were used as stimulator cells in an IFN-g-Elispot assay. T
estricted epitope (SL9) from the Gag p17 protein. Stimulating cells wer
or in an independent experiment, to YU-2 WT and Dnef at either low or
with EM71-1 cells. Activity of EM71-1 cells is depicted as the number of
ells were pulsed with the cognate peptide (SL9, 1 mg/ml). In the experi
when the cognate peptide was used (not shown). Data are mean 6 Simmature DCs provides indirect evidence for the limited
contribution of these cells to the viral burden in vivo.DCs bind and capture HIV-1 through the DC-specific
type C lectin, DC-SIGN, which is the receptor for ICAM-3
(Geijtenbeek et al., 2000). Transmission of DC-associ-
ated virus to T cells involves the interaction of other
adhesion molecules, including LFA1/ICAM-1 and LFA3/
CD2 (Tsunetsugu-Yokota et al., 1997), indicating that
close contacts between the two cell types are required
for this process. We have investigated the role of Nef
during viral transmission from DCs to T cells. However,
R5 HIV-1 strains replicate in immature DCs in the ab-
sence of T cells, whereas Dnef viruses are altered in
their replication in primary lymphocytes. These consid-
erations precluded the study of the transmission of R5
strains and the use of primary lymphocytes for this part
of our study. We therefore followed the transmission of
the X4 strain NL43 from DCs to MT4 lymphoid cells, in
which Nef is dispensable for viral replication. We ob-
served similar replication kinetics for WT and Dnef vi-
ruses, strongly suggesting that Nef is not required for
X4-tropic HIV-1 transmission from DCs to T cells. The
productive infection of DCs by HIV-1 and their ability to
capture virus are thought to be mediated through sepa-
rate pathways (Blauvelt et al., 1997). Captured particles
accumulate in a trypsin-resistant compartment, in which
they retain their infectivity for several days (Blauvelt et al.,
1997; Geijtenbeek et al., 2000). We show here that im-
mature DCs similarly retain WT and Dnef HIV-1 strain
NL43 in an infectious state for at least 5 days. Altogether,
our experiments strongly suggest that Nef is not required
for virion capture, long-term intracellular accumulation,
and transmission of X4 strains to T lymphocytes by DCs.
Replication of HIV-1 in vivo is highly productive and
-1 virions. Immature DCs prepared from HLA-A21 HIV-seronegative
ector was the CD81 CTL line EM71-1, which recognizes an HLA-A2-
eated with AZT (5 mM), exposed to BRU WT and Dnef (250 ng p24) (A),
oculum (25 or 250 ng p24, respectively) (B). Cells were then incubated
ositive cells for 500 or 2500 effectors. As a positive control, stimulating
epicted in B, the IFN-g positive cells were too numerous to be counted
plicates and are representative of two independent experiments.ng HIV
he eff
e pretr
high in
IFN-g pcontinuous. Productively infected lymphocytes have a
half-life of less than 2 days and contribute to approxi-
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233Nef AND HIV REPLICATION IN DENDRITIC T-CELL COCULTURESmately 99% of the viremia (Perelson et al., 1996). We
show here that Dnef replication is severely compromised
in activated lymphocytes, confirming the importance of
the viral protein on HIV replication in PBMCs (Aiken and
Trono, 1995; Brown et al., 1999; de Ronde et al., 1992;
Glushakova et al., 1999; Miller et al., 1994; Spina et al.,
1994). Thus, the low viral loads observed in SIVDnef or in
HIVDnef-infected hosts (Deacon et al., 1995; Kestler et
al., 1991; Kirchoff et al., 1995) are most likely the conse-
quence of the replicative defect of mutated viruses in
lymphocytes. In unstimulated lymphocytes, it has been
reported that Nef may provide an activating signal nec-
essary for reaching a high level of productive infection
(Alexander et al., 1997; Brown et al., 1999; Glushakova et
al., 1999; Wang et al., 2000). That Nef is also required in
activated T cells suggests that other mechanisms are
involved in the positive effects of this viral protein. Inter-
estingly, we observed strain-specific differences in the
dependence on Nef for replication in activated PBMCs.
The defect of Dnef virus was minimal with NLAD8,
whereas it was much more pronounced with YU-2 and
NL43. Coreceptor usage apparently does not account for
these differences, because both YU-2 and NLAD8 uses
CCR5 for entry. In primary macrophages, opposite re-
sults concerning the requirement of Nef for HIV-1 repli-
cation have been reported. Whereas Dnef replication of
YU-2 or SF162 strains is severely compromised in mac-
rophages (Brown et al., 1999; Miller et al., 1994), similar
replication efficiencies were observed with Dnef and
wild-type viruses for the ADA isolate or for a NL43/BAL
chimera (Meylan et al., 1998; Swingler et al., 1999). Con-
sistent with our observation in lymphocytes, these differ-
ences may also be virus strain-dependent. Molecular
and cellular mechanisms underlying these differences
are not fully understood. The NLAD8 and NL43 viruses
that we used here are isogenic strains differing only in
the env gene. This indicates that the Nef defect may be
odulated by Env proteins. We previously reported that
ef modulates the surface expression and cytopathic
ffects of gp120/gp41 complexes (Schwartz et al., 1993).
ef also enhances envelope glycoprotein incorporation
nto virions (Lama et al., 1999; Ross et al., 1999). There-
ore, it will be of interest to compare the effects of Nef on
p120/gp41 function using different isogenics strains.
Messmer et al. recently reported a positive role of SIV
ef on SIVmac239 replication in cocultures of simian
mmature DCs and T cells (Messmer et al., 2000). Our
esults indicate that SIV and HIV Nef share functional
omologies in supporting viral replication in immature
C-T cells mixtures. However, our study differs from that
f Messmer et al. in several respects. First, the effects of
IV Nef on viral replication in DCs alone or on viral
ransmission from DCs to T cells were not examined by
essmer et al. because immature DCs are not suscep-tible to SIVmac239 replication (Messmer et al., 2000). We
how here that the prominent role of HIV-1 Nef on viraleplication in this experimental system occurs in lympho-
ytes. Second, we observed that Nef is required for
fficient HIV-1 replication in DC-T cell cultures irrespec-
ive of the activation state of T lymphocytes. In contrast,
essmer et al. reported that when DC-T cell cultures
ere activated with the superantigen SEB, both wt and
nef SIVmac239 replicated with identical levels and ki-
etics (Messmer et al., 2000). This discrepancy could be
ue to experimental differences, or to inherent differ-
nces between human and monkey cells or virus strains
sed. On the other hand, the functional organization of
IV and HIV-1 Nef is different and includes variations in
he ability to bind the TCR (Howe et al., 1998; Schaefer et
l., 2000). This could influence the respective abilities of
IV and HIV-1 Nef to stimulate viral replication in acti-
ated or inactivated lymphocytes. Moreover, by using
hree HIV-1 isolates, we point out that the requirement for
ef in DC-T cell cocultures is viral strain-specific and
epends on Env proteins.
DCs can stimulate resting, naive T lymphocytes and,
s a consequence, initiate CTL immune responses in
ivo (Banchereau and Steinman, 1998). Following antigen
apture in peripheral tissues, immature DCs migrate to
econdary lymphoid organs. As cells travel, they mature,
rocess antigens for presentation, and acquire the ability
o attract and activate resting CD81 cytotoxic T lympho-
ytes. In most cells, MHC-I molecules associate exclu-
ively with peptides derived from endogenous cytosolic
roteins. However, stimulation of CTLs against trans-
lants, tumors, bacteria, or viruses that do not infect
PCs requires presentation of exogenous antigens by
Cs (Albert et al., 1998; Sigal et al., 1999; Yewdell et al.,
1999). We have shown that immature DCs process anti-
gens from incoming HIV-1 virions through the MHC-I-
restricted presentation pathway, leading to CTL activa-
tion in the absence of viral protein neosynthesis
(Buseyne et al., 2001). Presentation of exogenous HIV-1
antigens required adequate virus-receptor interactions
and fusion of viral and cellular membranes (Buseyne et
al., 2001). Thus, the only step of the viral cycle that is
required for CTL stimulation by DCs is virus entry. Pre-
sentation of epitopes before the synthesis of viral pro-
teins may be essential for CTL activation, since Nef
down-regulates MHC-I expression and decreases im-
mune recognition of cells that become productively in-
fected (Collins et al., 1998; Schwartz et al., 1996). We
show here that presentation of a Gag epitope derived
from incoming virions is observed with similar efficien-
cies for WT and nef-deleted viruses. Our results strongly
suggest that Nef does not influence the ability of incom-
ing virions to be processed for MHC-I exogenous pre-
sentation. Moreover, they provide a likely explanation of
how anti-HIV CTLs may be induced despite the down-
modulating activity of Nef on MHC-I.In summary, we have shown here that Nef is required
for optimal HIV-1 replication in mixtures of immature DCs
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234 PETIT ET AL.and T cells, in a system relevant for the physiopathology
of the infection. Furthermore, wild-type and Dnef virions
are similarly captured and processed for MHC-I re-
stricted exogenous presentation by DCs. Altogether,
these results help explain how Nef affects viral spread
and immune responses in vivo.
MATERIALS AND METHODS
eneration of mononuclear subsets
DCs were prepared as described using a VacCell
rocessor (IDM, Paris, France) (Goxe et al., 1998). Briefly,
peripheral blood mononuclear cells (PBMCs) from leu-
kapheresis were cultured 7 days in serum-free AIM-V
medium (Gibco) supplemented with 500 U/ml GM-CSF (a
kind gift from Novartis) and 50 ng/ml IL-13 (Sanofi), and
DCs were isolated by elutriation. This isolation proce-
dure yielded CD1a1 MHC-I1, MHC-II1, CD642, CD832,
CD80 low, CD86 low cells, a phenotype corresponding to
immature DCs. DC purity was .95%. PBMCs were acti-
vated with PHA and cultivated in the presence of IL-2 (50
U/ml, Chiron). Nonactivated PBMCs were allowed to
adhere for 2 h at 37°C. Nonadherent cells were washed
off and used for further studies.
Flow cytometry analysis
DCs were washed in PBS and incubated with mono-
clonal antibodies (mAbs) for 30 min at 4°C in PBA (1%
bovine serum albumin, 0.1% sodium azide in PBS). After
staining, cells were fixed in PBA containing 1% parafor-
maldehyde and analyzed with a FACScalibur cytoflu-
orometer (Becton–Dickinson). Cells were stained with
the following mAbs: anti-CD4: Leu 3A (IgG1, Becton–
Dickinson), anti-CXCR4 (IgG2a, 12G5), and anti-CCR5
(IgG2a, 2D7), obtained through the NIH AIDS Research
and Reference Reagent Program. As a control, cells were
stained with an isotypic IgG2a mAb (Becton–Dickinson).
Secondary antibody was a phycoerythrin-labeled goat
anti-mouse antibody (Southern Biotechnology).
Viruses and infections
The use of X4-tropic NL43 WT and Dnef, and BRU WT
and Dnef HIV-1, has been described elsewhere
(Schwartz et al., 1995). The R5-tropic NLAD8 WT strain
was a kind gift of Eric Freed (Englund et al., 1995). It
carries a portion of the env gene from the R5-tropic clone
AD8 on a pNL4–3 backbone (Englund et al., 1995).
NLAD8 Dnef was generated by inserting a frameshift
mutation at the unique XhoI site of the viral genome. The
R5-tropic YU-2 WT and Dnef strains were a kind gift of
Mark Feinberg (Miller et al., 1994). Viruses were pro-
duced by transient transfection and used for infections
as described (Schwartz et al., 1998). For all strains, in
1 1single-cycle replication assays using HeLa-CD4 CCR5
LTR–LacZ indicator cells (Mare´chal et al., 1998), Dnefinfectivity was reduced by 20 to 60% compared to that of
WT (not shown). Infections were carried out as described
(Schwartz et al., 1995). When stated, PBMCs were acti-
vated 3 days before infection with the indicated viral
strains. PBMCs were maintained in the presence of IL-2
throughout the experiments. For coculture infections,
DCs were first exposed to the indicated doses of viruses.
After an overnight incubation at 37°C, cells were washed
and target cells (PBMCs or MT4 cells) were then added
at a ratio of four targets for one DC. After infection, DCs
were cultivated in RPMI medium (Gibco) supplemented
with 10% human AB1 serum. Similar viral replication
curves were obtained when DCs were cultivated in se-
rum-free AIM-V medium supplemented with GM-CSF
and IL-13 (not shown). Viral replication was assessed by
measuring p24 production by ELISA (Du Pont de
Nemours-NEN) in culture supernatants.
CTL line
The CTL line EM71-1 has been described elsewhere
(Buseyne et al., 2001). It was derived from a child perinatally
infected with HIV-1 by repeated stimulations of PBMC with
irradiated autologous B-EBV cells coated with the p17 Gag
peptide SLYNTVATL (SL9, originally described by Tsomides
et al., 1994) in the presence of allogeneic irradiated PBMC.
Peptide recognition was HLA-A2 restricted, with a SD50 of
0.5 ng/ml in 51Cr release assays (not shown). This epitope
is present in BRU and YU-2 HIV-1 strains. Ninety-seven
percent of EM71-1 cells were CD81 and CD31, and 94%
ere stained with SL9-HLA-A2 tetramers (Buseyne et al.,
001). CTL culture conditions were as described (Buseyne
t al., 1998).
lispot assay
The reverse-transcriptase inhibitor AZT (5 mM, Sigma)
as added to cells 3 to 5 h before exposure to viruses
nd maintained throughout the assay. DCs (2 3 106 cells)
ere exposed to the indicated viruses for 1 h in a volume
f 1 ml and diluted twice in fresh medium before over-
ight incubation. Viral inoculum was 25 or 250 ng of
24/2 3 106 cells. Stimulator cells (DCs) were washed
twice before incubation with effectors. IFN-g production
as measured in a Elispot assay as described else-
here (Buseyne et al., 2001). Briefly, targets and effectors
were incubated overnight in nitrocellulose-bottomed 96-
well plates (Millipore) coated with anti-IFN-g mAb 1-D1K
15 mg/ml, Mabtech). IFN-g production was revealed by
sequential incubations with biotinylated anti-IFN-g mAb
7-B6-1 (1 mg/ml, Mabtech), streptavidine-alkaline phos-
phatase (0.5 U/ml, Boehringer Mannheim), and BCIP-
NBT substrate (Promega). Positive spots were counted
using a binocular microscope.
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